Topic

Articles

A top-down analysis of the decentralized trial model’s benefits and impact on the industry

Navigating a Decentralized Trial Model and the Changing Clinical Landscape During COVID-19

Operational and patient burden considerations for self-collection of blood specimens in clinical trials

Self-collection of Blood Specimens in Clinical Trials

Life sciences companies challenged by need to minimize health risks without sacrificing data quality during pandemic.

Impact of COVID-19 on Phase I Clinical Activities

Non-profit biotech organization Cure Rare Disease utilizes collaboration amidst COVID-19 pandemic to catalyze speed of therapeutic research.

Improving Drug Development for Rare Patients Post-COVID

COVID-19 speeds up clinical research and creates new advancements within industry.

Shifting Expectations for Clinical Development 

Clinical operations professionals, burdened by lack of data standardization, turn to technology in hopes of streamlining regulatory processes for the future.

Regulatory Data: How Technology Can Help ClinOps Survive

The fear of exposure to SARS-CoV-2 in healthcare settings has deterred people from seeking care for non-COVID-19 diseases. One solution to patient care and biomedical research disruptions is implementing remote solutions for conducting research and collecting samples.

Pandemic-Proof Clinical Study Start-Up

Craig Serra, who works in Clinical Technology and Innovation at Novartis, discusses  his perspectives on clinical innovation implementation during COVID.

How Novartis Overcame COVID Through Clinical Innovation

A discussion of various topics amongst TMF experts from Questex’s 2020 Global TMF Summit. 

Update on Maintaining TMF Quality

A discussion of how sponsors, CROs, and sites are adapting their operational models to maintain patient safety, data quality, and integrity in the COVID-19 pandemic. 

Clinical Operations